CN105853627A - Chinese and western medicine complex formula for treating duck virus hepatitis - Google Patents

Chinese and western medicine complex formula for treating duck virus hepatitis Download PDF

Info

Publication number
CN105853627A
CN105853627A CN201610363642.7A CN201610363642A CN105853627A CN 105853627 A CN105853627 A CN 105853627A CN 201610363642 A CN201610363642 A CN 201610363642A CN 105853627 A CN105853627 A CN 105853627A
Authority
CN
China
Prior art keywords
grams
gram
western medicine
herba
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610363642.7A
Other languages
Chinese (zh)
Inventor
许明天
张瑞杰
侯强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suqian Ruitai Agricultural Development Co Ltd
Original Assignee
Suqian Ruitai Agricultural Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suqian Ruitai Agricultural Development Co Ltd filed Critical Suqian Ruitai Agricultural Development Co Ltd
Priority to CN201610363642.7A priority Critical patent/CN105853627A/en
Publication of CN105853627A publication Critical patent/CN105853627A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese and western medicine complex formula for treating duck virus hepatitis. The complex formula includes 25-35 g of poria cocos peel, 25-35 g of rhizoma alismatis, 5-8 g of polyporus umbellatus, 18-22 g of cassia twigs, 18-22 g of rhizoma atractylodis, 45-55 g of the bark of ash, 45-55 g of Herba Artemisiae Scopariae, 18-22 g of fructus gardeniae, 15-25 g of Radix et Rhizoma Rhei, 28-35 g of radix puerariae, 40-45 g of abrotani herba, 8-12 g of Cotinus coggygria Scop., 4-6 g of Triquetrous Tadehagi, 8-12 g of Endives flowers, 18-22 g of virustat, 4-6 g of camphor, 75-85 g of potassium chloride, 45-55 g of sodium bicarbonate, 18-25 g of decavitamin B and 500-520 g of auxiliaries. The Chinese and western medicine complex formula is reasonable in matching, has functions of tonifying liver and spleen, clearing away heat and toxic materials, eliminating inflammation and protecting liver, and dispelling wind and removing phlegm, has a good effect on treating duck virus hepatitis, can enhance the immunity of ducks and enhance the appetite, and is precise in treatment effect, high in cure rate and free of medicine residues, and ducks can not get medicine resistance easily after taking medicine.

Description

A kind of Chinese medicine and western medicine compound prescription treating duck viral hepatitis
Technical field
The present invention relates to a kind of Chinese medicine and western medicine compound prescription treating duck viral hepatitis, belong to animal medicinal composition field.
Background technology
Duck viral hepatitis is a kind of Acute exposure sexually transmitted disease being caused duckling by DHV, clinically to fall ill suddenly, to propagate fast, mortality rate height, cuing open inspection liver has obvious petechia and ecchymosis to be characterized, clinically to fall ill suddenly, to propagate fast, mortality rate height, cuing open inspection liver has obvious petechia and ecchymosis to be characterized, and duck viral hepatitis is that planting of duckling propagates rapid and that height is lethal infectious disease；Primary disease analyzes the cause of disease with theory of Chinese medical science, duckling " the spleen tending to insufficiency usually ", appetite is prosperous by force, and digestive function is poor in addition, it is susceptible to suffer from enteritis, the diseases such as diarrhoea, and " the liver being liable to excess ", heat-transformation in ill rear easily biography, Chang Yindong liver-wind, being susceptible to suffer from viral hepatitis, other internal organs are ill also tends to cause mixed infection, endangers liver, intestinal, spleen, each internal organs of stomach；The ill virus hepatitis of duckling, card belongs to epidemic febrile disease scope, caused for experiencing the heresy of epidemic disease.
Summary of the invention
It is an object of the invention to provide a kind of Chinese medicine and western medicine compound prescription treating duck viral hepatitis.
To achieve these goals, the present invention adopts the following technical scheme that
The Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis, its constitutive material is: Cortex Sclerotii Poriae 25-35 gram, Rhizoma Alismatis 25-35 gram, Polyporus 5-8 gram, Ramulus Cinnamomi 18-22 gram, Rhizoma Atractylodis 18-22 gram, Cortex Fraxini 45-55 gram, Artemisia anethoicles Mattf 45-55 gram, Fructus Gardeniae 18-22 gram, Radix Et Rhizoma Rhei 15-25 gram, Radix Puerariae 28-35 gram, Herba Artemisiae Annuae 40-45 gram, Ramulus et folium cotini coggygriae 8-12 gram, Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 4-6 gram, Flos Sonchi arvensis 8-12 gram, moroxydine 18-22 gram, Camphora 4-6 gram, 75-85 gram of potassium chloride, sodium bicarbonate 45-55 gram, compound vitamin B 18-25 gram, adjuvant 500-520 gram.
The Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis, its constitutive material is: Cortex Sclerotii Poriae 30 grams, Rhizoma Alismatis 30 grams, Polyporus 5 grams, Ramulus Cinnamomi 20 grams, Rhizoma Atractylodis 20 grams, Cortex Fraxini 50 grams, Artemisia anethoicles Mattf 50 grams, Fructus Gardeniae 20 grams, Radix Et Rhizoma Rhei 20 grams, Radix Puerariae 30 grams, Herba Artemisiae Annuae 42 grams, Ramulus et folium cotini coggygriae 10 grams, Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 5 grams, Flos Sonchi arvensis 10 grams, moroxydine 20 grams, Camphora 5 grams, 80 grams of potassium chloride, sodium bicarbonate 50 grams, compound vitamin B 20 grams, adjuvant 508 grams.
The Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis, described adjuvant is one or more in oral glucose, anhydrous glucose, auxiliary U.S. powder or Matrii Sulfas Exsiccatus.
Preparation method and Therapeutic Method: weigh each raw material by the weight portion of constitutive material, grind to form fine powder, first mix other raw material stirring in addition to adjuvant, and the adjuvant with corresponding mass share is thoroughly mixed the most again, packaging；Therapeutic Method is that the medicine according to the present invention carries out mixed feeding with complete feed 2:1000.
Beneficial effects of the present invention:
The reasonable mixture ratio of the present invention, there is invigorating liver and spleen, heat-clearing and toxic substances removing, antiinflammatory protects the liver, dispelling pathogenic wind and eliminating phlegms etc. act on, and treatment duck viral hepatitis effect is notable, and can strengthen the immunity of duck class, appetite strengthening, determined curative effect of the present invention, cure rate are high, no drug residue, and duck class is not likely to produce drug resistance after taking.
Detailed description of the invention
Embodiment 1: the Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis, its constitutive material is: Cortex Sclerotii Poriae 30 grams, Rhizoma Alismatis 30 grams, Polyporus 5 grams, Ramulus Cinnamomi 20 grams, Rhizoma Atractylodis 20 grams, Cortex Fraxini 50 grams, Artemisia anethoicles Mattf 50 grams, Fructus Gardeniae 20 grams, Radix Et Rhizoma Rhei 20 grams, Radix Puerariae 30 grams, Herba Artemisiae Annuae 42 grams, Ramulus et folium cotini coggygriae 10 grams, Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 5 grams, Flos Sonchi arvensis 10 grams, moroxydine 20 grams, Camphora 5 grams, 80 grams of potassium chloride, sodium bicarbonate 50 grams, compound vitamin B 20 grams, adjuvant 508 grams.
The Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis, described adjuvant is one or more in oral glucose, anhydrous glucose, auxiliary U.S. powder or Matrii Sulfas Exsiccatus.
Preparation method and Therapeutic Method: weigh each raw material by the weight portion of constitutive material, grind to form fine powder, first mix other raw material stirring in addition to adjuvant, and the adjuvant with corresponding mass share is thoroughly mixed the most again, packaging；Therapeutic Method is that the medicine according to the present invention carries out mixed feeding with complete feed 2:1000.

Claims (3)

1. the Chinese medicine and western medicine compound prescription treating duck viral hepatitis, it is characterised in that its constitutive material is: Cortex Sclerotii Poriae 25-35 gram, Rhizoma Alismatis 25-35 gram, Polyporus 5-8 gram, Ramulus Cinnamomi 18-22 gram, Rhizoma Atractylodis 18-22 gram, Cortex Fraxini 45-55 gram, Artemisia anethoicles Mattf 45-55 gram, Fructus Gardeniae 18-22 gram, Radix Et Rhizoma Rhei 15-25 gram, Radix Puerariae 28-35 gram, Herba Artemisiae Annuae 40-45 gram, Ramulus et folium cotini coggygriae 8-12 gram, Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 4-6 gram, Flos Sonchi arvensis 8-12 gram, moroxydine 18-22 gram, Camphora 4-6 gram, 75-85 gram of potassium chloride, sodium bicarbonate 45-55 gram, compound vitamin B 18-25 gram, adjuvant 500-520 gram.
The Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis the most according to claim 1, it is characterised in that its constitutive material is: Cortex Sclerotii Poriae 30 grams, Rhizoma Alismatis 30 grams, Polyporus 5 grams, Ramulus Cinnamomi 20 grams, Rhizoma Atractylodis 20 grams, Cortex Fraxini 50 grams, Artemisia anethoicles Mattf 50 grams, Fructus Gardeniae 20 grams, Radix Et Rhizoma Rhei 20 grams, Radix Puerariae 30 grams, Herba Artemisiae Annuae 42 grams, Ramulus et folium cotini coggygriae 10 grams, Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 5 grams, Flos Sonchi arvensis 10 grams, moroxydine 20 grams, Camphora 5 grams, 80 grams of potassium chloride, sodium bicarbonate 50 grams, compound vitamin B 20 grams, adjuvant 508 grams.
The Chinese medicine and western medicine compound prescription for the treatment of duck viral hepatitis the most according to claim 1, it is characterised in that described adjuvant is one or more in oral glucose, anhydrous glucose, auxiliary U.S. powder or Matrii Sulfas Exsiccatus.
CN201610363642.7A 2016-05-30 2016-05-30 Chinese and western medicine complex formula for treating duck virus hepatitis Pending CN105853627A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610363642.7A CN105853627A (en) 2016-05-30 2016-05-30 Chinese and western medicine complex formula for treating duck virus hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610363642.7A CN105853627A (en) 2016-05-30 2016-05-30 Chinese and western medicine complex formula for treating duck virus hepatitis

Publications (1)

Publication Number Publication Date
CN105853627A true CN105853627A (en) 2016-08-17

Family

ID=56641574

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610363642.7A Pending CN105853627A (en) 2016-05-30 2016-05-30 Chinese and western medicine complex formula for treating duck virus hepatitis

Country Status (1)

Country Link
CN (1) CN105853627A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1939454A (en) * 2006-06-13 2007-04-04 天津生机集团有限公司 Chinese medicinal composition for duck
CN101396427A (en) * 2007-09-30 2009-04-01 天津瑞普生物技术集团有限公司 Traditional Chinese medicine oral liquid for treating poultry virus hepatitis and hepatic injury
CN101757181A (en) * 2008-10-30 2010-06-30 天津生机集团股份有限公司 Traditional Chinese medicine composition for preventing and treating duck virus hepatitis and preparation method thereof
CN104189704A (en) * 2014-08-17 2014-12-10 严中明 Pharmaceutical composition for treating duck viral hepatitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1939454A (en) * 2006-06-13 2007-04-04 天津生机集团有限公司 Chinese medicinal composition for duck
CN101396427A (en) * 2007-09-30 2009-04-01 天津瑞普生物技术集团有限公司 Traditional Chinese medicine oral liquid for treating poultry virus hepatitis and hepatic injury
CN101757181A (en) * 2008-10-30 2010-06-30 天津生机集团股份有限公司 Traditional Chinese medicine composition for preventing and treating duck virus hepatitis and preparation method thereof
CN104189704A (en) * 2014-08-17 2014-12-10 严中明 Pharmaceutical composition for treating duck viral hepatitis

Similar Documents

Publication Publication Date Title
CN101658551A (en) Honeysuckle composition for resisting virus diseases of pigs
CN101874883A (en) Traditional Chinese medicine for preventing and treating high fever diseases of pigs
CN102526671B (en) Traditional Chinese medicine composition for preventing and treating cough and cold and preparation method thereof
CN103006916A (en) Pure traditional Chinese medicine recipe for curing various animal diarrhoeal diseases and preparation method of pure traditional Chinese medicine recipe
CN100512860C (en) Medicine for preventing and controlling chicken infectious laryngotracheitis
CN103393870B (en) Traditional Chinese medicine composition for treating duck virus hepatitis and preparation method thereof
CN102688417A (en) Chinese medicinal composition for treating porcine reproductive and respiratory syndrome
CN103610977A (en) Efficient scourge-clearing and toxin-vanquishing medicament preparation method for livestock and poultry
CN101219171A (en) Chinese medicine for preventing and treating virosis of livestock and poultry
CN103751274A (en) Pharmaceutical composition for treating duck and goose flavivirus infection and preparation method thereof
CN102397528B (en) Compound propolis composition for treating chicken infectious anemia and preparation method thereof
CN101015661A (en) Medicine for treating herpes and wart
CN105853627A (en) Chinese and western medicine complex formula for treating duck virus hepatitis
CN102283889A (en) Pure Chinese medicinal composition for treating duck virus hepatitis and preparation method thereof
CN1130212C (en) Medicine for treating abdominal node and its preparing process
CN103142751B (en) Traditional Chinese medicine composition for treating piglet iron-deficiency anemia
CN102397533B (en) Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof
CN104147399A (en) Pharmaceutical preparation for swine fever
CN1079252C (en) Compound graceful jassamine preparation
CN104367670A (en) Traditional Chinese medicine granules for preventing and treating piglet bacterial enteritis and preparation method thereof
CN103169836A (en) Medicament for preventing and treating viral hepatitis of ducklings
CN102397529B (en) Compound propolis composition for treating chicken reticuloendotheliosis and preparation method thereof
CN103735608A (en) Traditional Chinese medicine composition as well as preparation method and application thereof
CN102397510B (en) Compound propolis composition for treating chicken Marek's disease and preparation method thereof
CN102125650A (en) Join shellfish cough and asthma powder

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160817

RJ01 Rejection of invention patent application after publication